Top Stocks to Watch on July 16, 2025: HDFC Life, ICICI GIC, Bajaj Finserv, HDB Financial, Ashok Leyland, Zydus Lifesciences, and More
As the Indian stock market continues to rebound amid optimistic domestic and global developments, several key stocks are expected to remain in focus on Wednesday, July 16, 2025. Notable companies making headlines include HDFC Life Insurance, ICICI Lombard General Insurance (GIC), Bajaj Finserv, HDB Financial Services, Ashok Leyland, and Zydus Lifesciences, among others.
Market Overview
On Tuesday, July 15, benchmark Indian indices saw a positive correction with the BSE Sensex rising by 317.45 points (0.39%) to close at 82,253.46, while NSE’s Nifty50 gained 113.50 points (0.45%) to settle at 25,195.80. Investor sentiment was buoyed by favorable signals, including prospects of an interim trade agreement between India and the United States, supporting trading activity on Dalal Street.
Stocks in the Spotlight
HDFC Life Insurance Company
HDFC Life reported impressive first-quarter financials with a 14.4% year-on-year (YoY) increase in net profit, reaching Rs 546 crore. The company’s total annualized premium equivalent (APE) grew 12.5% YoY to Rs 3,225 crore, driven by a 12.5% rise in retail APE to Rs 2,777 crore. Additionally, the value of new business rose 12.7% to Rs 809 crore. Asset under management (AUM) expanded 14.7% YoY to Rs 3.55 lakh crore, reflecting robust growth in its insurance book.
ICICI Lombard General Insurance Company
ICICI Lombard recorded a strong quarter with net profit increasing 28.7% YoY to Rs 747 crore. Gross written premium saw a marginal increase of 1.5% YoY to Rs 8,053 crore, and gross direct premium edged up by 0.6% YoY to Rs 7,735 crore. Net premium earned surged 14% YoY to Rs 5,136 crore, indicating improved underwriting performance.
Bajaj Finserv
Bajaj Finserv is in the news following the Insurance Regulatory and Development Authority of India’s (IRDAI) approval for the transfer of Allianz SE’s 26% shareholding in its insurance subsidiaries—Bajaj Allianz General Insurance and Bajaj Allianz Life Insurance—to Bajaj Finserv, Bajaj Holdings & Investment, and promoter group firm Jamnalal Sons. This move enhances promoter control over the insurance entities and could impact strategic decisions moving forward.
HDB Financial Services
The recently listed non-banking financial company (NBFC) announced a 2.4% YoY decline in net profit to Rs 568 crore for Q1FY26. However, net interest income increased by 18.3% YoY to Rs 2,092 crore, with net interest margins improving to 7.7%. The company reported a rise in both net and gross non-performing assets (NPAs). Profit before provisions and write-offs (PPOP) grew 17.2% to Rs 1,402 crore.
Ashok Leyland
Ashok Leyland shares will trade ex-bonus today with a 1:1 ratio. This corporate action highlights the company’s efforts to reward shareholders amid ongoing growth in the commercial vehicle sector.
Zydus Lifesciences
Zydus Lifesciences recently won final approval from the US Food and Drug Administration (USFDA) for its Celecoxib capsules in various strengths (50 mg, 100 mg, 200 mg, and 400 mg). Celecoxib is indicated for conditions involving pain and inflammation, such as arthritis and ankylosing spondylitis, adding to Zydus’s expanding global pharmaceutical footprint.
Other Noteworthy Updates
- Glenmark Pharmaceuticals witnessed a 10% jump in its stock price, reaching a new all-time high of Rs 2,094 per share.
- Biocon Biologics, a Biocon subsidiary, received USFDA approval for KIRSTY (Insulin Aspart-xjhz), an interchangeable biosimilar for NovoLog, used in diabetes management.
- Dixon Technologies India announced binding term sheets with Kunshan Q Tech Microelectronics and Chongqing Yuhai Precision Manufacturing for acquisition and joint venture initiatives in India.
- Kotak Mahindra Bank’s President and Chief Credit Officer, Phani Shankar, has resigned effective July 21, 2025. Upcoming Corporate Actions and Results
Several companies, including Tech Mahindra, ITC Hotels, Angel One, and L&T Technology Services, are scheduled to announce their quarterly earnings today for the June 2025 quarter. Additionally, shares of firms like Anant Raj, Piramal Pharma, Tata Consultancy Services, and Ashok Leyland will witness ex-dividend or ex-bonus trades, influencing short-term trading dynamics.
Investor Caution
While these stocks are currently in focus due to recent corporate developments and earnings announcements, investors are advised to exercise due diligence and consult with a qualified financial advisor before making investment decisions.
For continuous updates on market trends and company news, stay connected with Smart Money Mindset.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.